Baird Medical Investment Holdings Ltd(BDMD)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

Baird Medical Investment Holdings Ltd (BDMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BDMD at 26.6/100 on a 32-signal composite quality model, placing it at rank #2,610 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Baird Medical Investment Holdings Ltd reports quarterly revenue of $22.5M, net income of $-27.3M, free cash flow of $-1.4M. Top institutional holders of BDMD by reported 13-F value include Sculptor Capital, Clear Street Group, ARISTEIA CAPITAL, L.L.C., based on the most recent SEC filings. BDMD trades on the Nasdaq exchange and files with the SEC under CIK 1982444. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BDMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Baird Medical Investment Holdings Ltd directly from SEC EDGAR.